Current Research Studies
Cancer – PNOC 014: A Phase I/II and Target Validation Study of TAK-580 (MLN2480) for Children with Low-Grade Gliomas and Other RAS/RAF/MEK/ERK Pathway Activated Tumor
Condition or Therapy:
Low-grade glioma, TAK-580
What is the goal of this study?
The goal of this study is to assess how the drug TAK-580 responds in patients with low-grade glioma.
Who can join the study?
This study may be a good fit for children and young adults who:
- Are between 1 and 18 years old and
- Have low-grade glioma
What will happen if my child takes part in this study?
You can read more about this study on clinicaltrials.gov.
Who can I contact for more information?
To learn more, call 206-987-2106 or email the study coordinator.